{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:47:05Z","timestamp":1792860425370,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["T-000353"],"award-info":[{"award-number":["T-000353"]}],"id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["13CVD03"],"award-info":[{"award-number":["13CVD03"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.atherosclerosis.2018.12.019","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T11:37:16Z","timestamp":1545997036000},"page":"137-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia"],"prefix":"10.1016","volume":"283","author":[{"given":"Martine","family":"Paquette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5325","authenticated-orcid":false,"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.12.019_bib1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.12.019_bib2","first-page":"405","article-title":"Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population","volume":"140","author":"Gagn\u00e9","year":"1989","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.12.019_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1499-3872(14)60033-3","article-title":"Familial chylomicronemia syndrome related chronic pancreatitis: a single-center study","volume":"13","author":"Sisman","year":"2014","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.atherosclerosis.2018.12.019_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \"FCS score","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2018.12.019_bib5","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.12.019_bib6","series-title":"Protides of Biological Fluids","first-page":"243","article-title":"Specific assays for lipoprotein lipase and hepatic lipase activities of post-heparin plasma","author":"Nilsson-Ehle","year":"1978"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2018.12.019_bib7","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.12.019_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14779072.2017.1372193","article-title":"The burden of familial chylomicronemia syndrome from the patients' perspective","volume":"15","author":"Gelrud","year":"2017","journal-title":"Expert Rev. Cardiovasc Ther."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.12.019_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.mcg.0000436438.60145.5a","article-title":"Issues in hypertriglyceridemic pancreatitis: an update","volume":"48","author":"Scherer","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.12.019_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacl.2010.11.004","article-title":"Etiology and risk of lactescent plasma and severe hypertriglyceridemia","volume":"5","author":"Tremblay","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.12.019_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/ijcp.12507","article-title":"Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose-response meta-analysis","volume":"69","author":"Kunutsor","year":"2015","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.12.019_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2018.12.019_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2017.07.030","article-title":"Alterations in plasma triglycerides lipolysis in patients with history of multifactorial chylomicronemia","volume":"265","author":"Marmontel","year":"2017","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.12.019_bib14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199609193351203","article-title":"Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene","volume":"335","author":"Benlian","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.12.019_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018315508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018315508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:37:24Z","timestamp":1758155844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018315508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":15,"alternative-id":["S0021915018315508"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.12.019","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}